Astera Labs (NASDAQ:ALAB) Shares Up 5.4% – Should You Buy?

Astera Labs, Inc. (NASDAQ:ALAB)’s share price traded up 5.4% during trading on Monday . The company traded as high as $440.99 and last traded at $439.66. Approximately 5,545,140 shares traded hands during trading, a decline of 3% from the average daily volume of 5,704,791 shares. The stock had previously closed at $417.07.

Analyst Ratings Changes

ALAB has been the topic of several recent research reports. Needham & Company LLC upped their price target on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. JPMorgan Chase & Co. upped their price objective on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. TD Cowen raised their target price on shares of Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a research report on Wednesday, May 6th. Rothschild & Co Redburn assumed coverage on Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective for the company. Finally, Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 26th. Twelve research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $254.75.

Astera Labs Price Performance

The firm’s 50-day moving average price is $275.59 and its 200 day moving average price is $191.30. The firm has a market capitalization of $68.55 billion, a price-to-earnings ratio of 270.22, a price-to-earnings-growth ratio of 5.82 and a beta of 3.95.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. During the same period in the previous year, the firm posted $0.33 earnings per share. The business’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other news, CEO Jitendra Mohan sold 325,693 shares of the stock in a transaction dated Friday, April 17th. The shares were sold at an average price of $172.14, for a total transaction of $56,064,793.02. Following the transaction, the chief executive officer directly owned 4,079,322 shares in the company, valued at $702,214,489.08. This represents a 7.39% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the completion of the transaction, the director owned 319,863 shares in the company, valued at approximately $34,420,457.43. This trade represents a 36.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 2,161,256 shares of company stock worth $459,844,296. Insiders own 10.40% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

Hedge funds and other institutional investors have recently modified their holdings of the company. Empowered Funds LLC grew its stake in Astera Labs by 5.1% during the first quarter. Empowered Funds LLC now owns 9,606 shares of the company’s stock worth $1,053,000 after buying an additional 462 shares during the period. Carmignac Gestion purchased a new stake in shares of Astera Labs during the first quarter worth about $6,576,000. Shariaportfolio Inc. acquired a new position in shares of Astera Labs in the 1st quarter valued at approximately $5,304,000. Glenmede Trust Co. NA boosted its stake in Astera Labs by 2.7% during the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after acquiring an additional 51 shares during the last quarter. Finally, Verus Capital Partners LLC grew its stake in Astera Labs by 16.4% in the first quarter. Verus Capital Partners LLC now owns 3,849 shares of the company’s stock worth $422,000 after purchasing an additional 541 shares in the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.